Sort
326,823 grants matching “clinical trial”
University of Wisconsin Prostate SPORE
$2,085,688David F Jarrard · University Of Wisconsin-Madison · P50 · FY2024 · CA
Cancer as a Complex Adaptive System
$2,085,604Robert A Gatenby · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2015 · CA
Biomimetic Actinide Decorporation: Characterization and Preclinical Development
$2,085,577Kenneth N Raymond · University Of Calif-Lawrenc Berkeley Lab · RC2 · FY2009 · AI
Hormonal Control of Calcium Metabolism
$2,085,431John T Potts · Massachusetts General Hospital · P01 · FY2019 · DK
MOTOR-Maternal Oral Therapy to Reduce Obstetric Risk
$2,085,187University Of North Carolina Chapel Hill · U01 · FY2004 · DE
Transition to Human Phase 1b Trials: Nonclinical Studies of an Anti-METH mAb
$2,085,133Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2016 · DA
Discovering and Exploiting Mechanisms of Neuroblastoma Therapy Resistance
$2,085,090John M Maris · Children'S Hosp Of Philadelphia · P01 · FY2021 · CA
Malaria Vaccine: Pfs25-rEPA
$2,085,065Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
CAR-T Therapy of Mesothelin Expressing Cancers
$2,085,050Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
PK/PD, METABOLIC, AND PRECLINICAL STUDIES - SRI INTERNATIONAL
$2,084,983Debra Burnin · Sri International · N01 · FY2023 · HD
1/2: An Anesthesia-Centered Bundle to Reduce Postoperative Pulmonary Complications: The PRIME-AIR Study
$2,084,948Marcos F Vidal Melo · Massachusetts General Hospital · UH3 · FY2020 · HL
Kaiser Permanente NCI National Community Oncology Research Program NCORP
$2,084,858Louis Fehrenbacher · Kaiser Foundation Research Institute · UG1 · FY2014 · CA
Cobre for Signal Transduction and Cancer
$2,084,768Laura F Gibson · West Virginia University · P20 · FY2009 · RR
Cobre for Signal Transduction and Cancer
$2,084,768Laura F Gibson · West Virginia University · P20 · FY2010 · RR
Cobre for Signal Transduction and Cancer
$2,084,768Laura F Gibson · West Virginia University · P20 · FY2008 · RR
PROMISE Trial: Clinical Coordinating Center
$2,084,633Pamela Susan Douglas · Duke University · R01 · FY2014 · HL
Integrated, Individualized, and Intelligent Prescribing (I3P) Clinical Trial Network
$2,084,595Josh F. Peterson · Vanderbilt University Medical Center · U01 · FY2020 · HG
GHESKIO HIV Clinical Trial Unit
$2,084,335Jean William Pape · Gheskio Center · U01 · FY2010 · AI
NYU Melanoma SPORE
$2,084,236Iman Osman · New York University School Of Medicine · P50 · FY2023 · CA
UNC CENTER FOR HEALTH PROMOTION AND DISEASE PREVENTION
$2,084,080Alice S. Ammerman · Univ Of North Carolina Chapel Hill · U48 · FY2013 · DP
Support for Registration Enabling Phase 3 Clinical Trial for Nanotechnology-Based Treatment of Carcinoma in Situ of the Oral Cavity (Stage 0 Oral Cancer)
$2,084,026Manijeh N Goldberg · Privo Technologies, Llc · R44 · FY2024 · CA
Alzheimer's dementia onset and progression in international cohorts (Amended)
$2,083,798Colin Masters · University Of Melbourne · R01 · FY2022 · AG
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM FOR AIDS
$2,083,770University Of North Carolina Chapel Hill · U01 · FY2004 · AI
The University of Texas MD Anderson Cancer Center SPORE in Melanoma
$2,083,190Patrick Hwu · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA
CURE SICKLE CELL INITIATIVE DATA STRATEGY AND DATA RESOURCES PROGRAM
$2,083,077Barbara L Kroner · Research Triangle Institute · OT3 · FY2025 · HL